Accreditation and Designation User Manual - OECI
Accreditation and Designation User Manual - OECI Accreditation and Designation User Manual - OECI
2.3. Infrastructures with a focus on cancer care (3 of 7) 2.3.1. per year = x gastrointestinal cancer: oesophagus C15 gastrointestinal cancer: stomach C16 gastrointestinal cancer: colon C18 gastrointestinal cancer: rectum C20H gastrointestinal cancer: liver C22 gastrointestinal cancer: pancreas C25 gastrointestinal cancer: Others New patients Number of Number of Total number Working with Multidisciplinary Clinical Number of (newly surgical Chemotherapy of sessions guidelines meeting pathways patients admitted and procedures (numbers/ (RT) (Y/N) (Y/N) (Y/N) (RT) referred) (numbers/ patients) patients) 2.4. Infrastructures with a focus on cancer care (4 of 7) 2.4.1. per year = x gynaecological cancer: ovary C56H gynaecological cancer: cervix C53 gynaecological cancer: endometrial C54 gynaecological cancer: Others New patients Number of Number of Total number Working with Multidisciplinary Clinical Number of (newly surgical Chemotherapy of sessions guidelines meeting pathways patients admitted and procedures (numbers/ (RT) (Y/N) (Y/N) (Y/N) (RT) referred) (numbers/ patients) patients) 2.5. Infrastructures with a focus on cancer care (5 of 7) 2.5.1. per year = x head and neck cancer: larynx C32 head and neck cancer: hypopharynx C13 head and neck cancer: oropharynx C10 head and neck cancer: nasapharynx C11 head and neck cancer: thyreoid C73H head and neck cancer: others New patients Number of Number of Total number Working with Multidisciplinary Clinical Number of (newly surgical Chemotherapy of sessions guidelines meeting pathways patients admitted and procedures (numbers/ (RT) (Y/N) (Y/N) (Y/N) (RT) referred) (numbers/ patients) patients) 30 / OECI Accreditation and Designation / Appendix III
2.6. Infrastructures with a focus on cancer care (6 of 7) 2.6.1. per year = x haematological malignancies: Hodgkin Lymphoma C81 haematological malignancies: Non Hodgkin Lymphoma C82 haematological malignancies: Myeloma C90 haematological malignancies: All leukaemia neuro-oncological: Central nervous system C71-C72 neuro-oncological: others New patients Number of Number of Total number Working with Multidisciplinary Clinical Number of (newly surgical Chemotherapy of sessions guidelines meeting pathways patients admitted and procedures (numbers/ (RT) (Y/N) (Y/N) (Y/N) (RT) referred) (numbers/ patients) patients) 2.7. Infrastructures with a focus on cancer care (7 of 7) 2.7.1. per year = x paediatric malignancies: all cancers (age 0
- Page 36 and 37: 5.6 Step 6: Payment stage 2 fee If
- Page 38 and 39: Preparation of the auditors’ team
- Page 40 and 41: Performing the peer review Executor
- Page 42 and 43: 5.8.1 Week 1-6: Reporting by the au
- Page 44 and 45: 5.8.2 Step 8: activities and respon
- Page 46 and 47: 5.9 Step 9: Formulate improvement p
- Page 48 and 49: 5.10.1 Evaluation of the A&D Progra
- Page 50 and 51: Intermediate self-assessment (optio
- Page 52 and 53: Owner: OECI Organisation of Europea
- Page 54 and 55: Owner: OECI Organisation of Europea
- Page 56 and 57: Owner: OECI Organisation of Europea
- Page 58 and 59: 2 / OECI Accreditation and Designat
- Page 60 and 61: Qualitative Questionnaire 1. Genera
- Page 62 and 63: 1.3.2. Administration of cytostatic
- Page 64 and 65: 1.4.6. Roles and tasks of the membe
- Page 66 and 67: 1.4.12. Registration and evaluation
- Page 68 and 69: 1.5.5. Quality assurance in all are
- Page 70 and 71: 2.4.5. Smoking control in the cance
- Page 72 and 73: 3.4.4. Palliative and terminal care
- Page 74 and 75: 4. Research, innovation and develop
- Page 76 and 77: 4.3. Resources and materials 4.3.1.
- Page 78 and 79: 5. Teaching and continuing educatio
- Page 80 and 81: 6. Patient related 6.4. Process con
- Page 82 and 83: 6.5. Safeguarding the quality syste
- Page 84 and 85: 1.4.7. at national level at regiona
- Page 88 and 89: 2.9. Radiology 2.9.1. Number of CT
- Page 90 and 91: 2.15. Facilities 2.15.1. On site Ac
- Page 92 and 93: 3.4. Human resources (4) 3.4.1. Pat
- Page 94 and 95: 4.3. Structures 4.3.1. Yes No not a
- Page 96 and 97: 5. Education 5.1. Education 5.1.1.
- Page 98 and 99: Planning of the project Start Expla
- Page 100 and 101: Go to the qualitative and quantitat
- Page 102 and 103: 3. Before moving to the next item p
- Page 104 and 105: The following screen will appear. F
- Page 106 and 107: • Close the questionnaire if you
- Page 108 and 109: Print only the questions or the ful
- Page 110 and 111: Workspace: Go to the questionnaires
- Page 112 and 113: 2. Preparing a peer review Open a q
- Page 114 and 115: To view the remarks and the score o
- Page 116 and 117: 2 / OECI Accreditation and Designat
- Page 118 and 119: Qualitative Questionnaire 1. Genera
- Page 120 and 121: 1.3.2. Administration of cytostatic
- Page 122 and 123: 1.4.6. Roles and tasks of the membe
- Page 124 and 125: 1.4.12. Registration and evaluation
- Page 126 and 127: 1.5.5. Quality assurance in all are
- Page 128 and 129: 2.4.5. Smoking control in the cance
- Page 130 and 131: 3.4.4. Palliative and terminal care
- Page 132 and 133: 4. Research, innovation and develop
- Page 134 and 135: 4.3. Resources and materials 4.3.1.
2.6. Infrastructures with a focus on cancer care (6 of 7)<br />
2.6.1. per year = x<br />
haematological malignancies:<br />
Hodgkin Lymphoma C81<br />
haematological malignancies:<br />
Non Hodgkin Lymphoma C82<br />
haematological malignancies:<br />
Myeloma C90<br />
haematological malignancies:<br />
All leukaemia<br />
neuro-oncological:<br />
Central nervous system C71-C72<br />
neuro-oncological:<br />
others<br />
New patients Number of Number of Total number Working with Multidisciplinary Clinical Number of<br />
(newly surgical Chemotherapy of sessions guidelines meeting pathways patients<br />
admitted <strong>and</strong> procedures (numbers/ (RT) (Y/N) (Y/N) (Y/N) (RT)<br />
referred) (numbers/ patients)<br />
patients)<br />
2.7. Infrastructures with a focus on cancer care (7 of 7)<br />
2.7.1. per year = x<br />
paediatric malignancies:<br />
all cancers (age 0
Change language